Skip to main content
Clinical Trials/CTRI/2018/09/015772
CTRI/2018/09/015772
Not yet recruiting
Phase 2

Investigating the efficacy of dual stimulation of tDCS and rTMS Neuro-modulation therapy of Major depression - DNIBS-MD

Director NIMHANS0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: G- Mental Health
Sponsor
Director NIMHANS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Director NIMHANS

Eligibility Criteria

Inclusion Criteria

  • Individuals with a diagnosis of moderate or severe depression according to ICD\-10 diagnosed by a psychiatrist would be recruited if they continue to have at least moderate depressive symptoms as defined clinically and using the HDRS cut\-off score of more than 17 even after at least 4\-weeks of adequate antidepressant trial with any conventional antidepressant medication

Exclusion Criteria

  • 1\.Patients aged \< 18 and \> 60 years of age
  • 2\.If patient is on any psychotropic (other than antidepressant medications, which is kept constant throughout the study period unless clinically required), anticholinergic or cardiac medications
  • 3\.Patients with suicidal tendencies or psychotic depression
  • 4\.Patients with any co\-morbid cardiac or neurological disorders that can increase the risk of TMS related complications or are having a contraindication for TMS/tDCS treatment
  • 5\.Pregnant/lactating patients
  • 6\.Failure of other organ systems or systemic illness that could affect autonomic function or participantsâ?? ability to cooperate

Outcomes

Primary Outcomes

Not specified

Similar Trials